Publications

Targeted degradation of oncogenic KRAS G12V triggers antitumor immunity in lung cancer models

 130
Targeted degradation of oncogenic KRAS G12V triggers antitumor immunity in lung cancer models

Tags:

Previous Article

Increased cholesterol synthesis drives neurotoxicity in multiple sclerosis

Next Article

Animal model for antitumor immunity in lung cancer

Related Posts

Basal progenitors as drivers of neocortical expansion

Basal progenitors as drivers of neocortical expansion

 80

Single-cell transcriptomic and functional studies identify glial state changes and a role for inflammatory RIPK1 signaling in ALS pathogenesis

Single-cell transcriptomic and functional studies ident...

 151

Mechanisms suppressing noncoding translation

Mechanisms suppressing noncoding translation

 139